Showing results (1-10 of 327) with videos related to

Sort By:
Pageof 33
Handbook of Experimental Pharmacology|January 29, 2019
Soluble Guanylate Cyclase Stimulators and ActivatorsPeter Sandner, Daniel P Zimmer, G Todd Milne, et al.
Expert Opinion on Therapeutic Patents|January 4, 2021
Soluble guanylate cyclase stimulators and their potential use: a patent reviewPeter Sandner, Alexandros Vakalopoulos, Michael G Hahn, et al.
British Journal of Pharmacology|October 2, 2021
Soluble GC stimulators and activators: Past, present and futurePeter Sandner, Markus Follmann, Eva Becker-Pelster, et al.
Nitric Oxide : Biology and Chemistry|May 9, 2018
Discovery and development of sGC stimulators for the treatment of pulmonary hypertension and rare diseasesPeter Sandner, Eva-Maria Becker-Pelster, Johannes Peter Stasch
European Respiratory Review : an Official Journal of the European Respiratory Society|March 20, 2024
The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclaseRaymond L Benza, Ekkehard Grünig, Peter Sandner, et al.
FEBS Open Bio|April 12, 2017
Inhibition of the TGFβ signalling pathway by cGMP and cGMP-dependent kinase I in renal fibrosisElisabeth Schinner, Veronika Wetzl, Andrea Schramm, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2013
Identification of acidic heterocycle-substituted 1H-pyrazolo[3,4-b]pyridines as soluble guanylate cyclase stimulatorsNils Griebenow, Hartmut Schirok, Joachim Mittendorf, et al.
Handbook of Experimental Pharmacology|October 5, 2013
Soluble guanylate cyclase stimulators in pulmonary hypertensionJohannes-Peter Stasch, Oleg V Evgenov
Pageof 33